PSA AND ITS RELATION TO THE DEGREE OF DIFFERENTIATION OF PROSTATE CANCER

Authors

  • B. Lazarov Clinic of Urology, Multi-profile Hospital for Active Treatment “Saint Anna” Medical University-Varna, Varna, Bulgaria Author

DOI:

https://doi.org/10.15547/tjs.2025.01.007

Keywords:

Gleason score, ISUP grades, radical prostatectomy, prostate biopsy, BPH

Abstract

INTRODUCTION: Prostate-specific antigen (PSA) and Gleason score are two of the most important characteristics of prostate cancer. Their complex and ambiguous connection prompted us to examine it in a series of patients operated in our clinic. For the analysis we used the ISUP – grade system according to which the Gleason scores are summed up in 5 grades. METHODS: 195 patients were available for analysis. All patients underwent a transrectal biopsy of the prostate with subsequent radical prostatectomy (either open retropubic or laparoscopic) in the clinic of Urology, MHAT “Saint Anna” – Varna. For PSA, we used the value distribution in three categories: below 10, between 10 and 20 and above 20 ng/ml. RESULTS There was a statistically significant difference in ISUP grades between the PSA categories. This applied to both post-biopsy and postoperative ISUP-grades. The ISUP - grade in the group with PSA < 10 was statistically significantly lower than in the group with PSA >20. DISCUSSION/CONCLUSION: PSA and ISUP grades are related in both analyses, when the ISUP grade is determined after the biopsy and after the radical prostatectomy. This connection is found in spite of possible external influences (presence of benign prostatic hyperplasia together with the tumor).

References

Lilja H. Structure, function, and regulation of the enzyme activity of prostate-specific antigen. World J Urol. 11(4):188-91,1993 doi: 10.1007/BF00185066. PMID: 7508781.

Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. Oct 8;317(15):909-16, 1987 doi: 10.1056/NEJM198710083171501. PMID: 2442609.

Merriel SWD, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, Hamilton W. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. Feb 7;20(1):54, 2022 doi: 10.1186/s12916-021-02230-y. PMID: 35125113; PMCID: PMC8819971.

Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. Jun;173(6):1938-42, 2005 doi: 10.1097/01.ju.0000158155.33890.e7. Erratum in: J Urol. 2006 Jun;175(6):2369. PMID: 15879786; PMCID: PMC2948569.

Hinev A, Ganev T. Radical prostatectomy in cases of locally advanced prostatic carcinoma. Scripta scient med. 29(Suppl 4):57-61, 1997.

Goel S, Shoag JE, Gross MD, Al Hussein Al Awamlh B, Robinson B, Khani F, Baltich Nelson B, Margolis DJ, Hu JC. Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis. Eur Urol Oncol. Feb;3(1):10-20, 2020 doi: 10.1016/j.euo.2019.08.001. Epub 2019 Sep 4. PMID: 31492650.

Qi R, Foo WC, Ferrandino MN, Davis LG, Sekar S, Longo TA, Jibara G, Han T, Gokhan I, Moul JW. Over half of contemporary clinical Gleason 8 on prostate biopsy are downgraded at radical prostatectomy. Can J Urol. Oct;24(5):8982-8989q 2017 PMID: 28971784.

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. Feb;40(2):244-52, 2016 doi: 10.1097/PAS.0000000000000530. PMID: 26492179.

Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. Eur Urol. Mar;69(3):428-35. 2016 doi: 10.1016/j.eururo.2015.06.046. Epub 2015 Jul 10. PMID: 26166626; PMCID: PMC5002992.

Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol. May;61(5):1019-24, 2012 doi: 10.1016/j.eururo.2012.01.050. Epub 2012 Feb 8. PMID: 22336380; PMCID: PMC4659370.

Downloads

Published

2025-04-02

Issue

Section

Original Contributions

How to Cite

PSA AND ITS RELATION TO THE DEGREE OF DIFFERENTIATION OF PROSTATE CANCER. (2025). TRAKIA JOURNAL OF SCIENCES, 23(1), 4. https://doi.org/10.15547/tjs.2025.01.007

Similar Articles

You may also start an advanced similarity search for this article.